Sirtuin1-p53: A potential axis for cancer therapy
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Biochemistry
Reference205 articles.
1. Signaling, metabolism, and cancer: An important relationship for therapeutic intervention;Vaghari-Tabari;J. Cell. Physiol,2021
2. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA. Cancer. J. Clin,2021
3. Clinical cancer genomic profiling;Chakravarty;Nat. Rev. Genet,2021
4. Cancer-mutation network and the number and specificity of driver mutations;Iranzo;Proc. Natl. Acad. Sci. U. S. A,2018
5. Comparative Risk Assessment collaborating, Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors;Danaei;Lancet,2005
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Huaier inhibits autophagy and promotes apoptosis in T-cell acute lymphoblastic leukemia by down-regulating SIRT1;Heliyon;2024-09
2. Sirt1: An Increasingly Interesting Molecule with a Potential Role in Bone Metabolism and Osteoporosis;Biomolecules;2024-08-08
3. Antitumorigenic potential of Lactobacillus-derived extracellular vesicles: p53 succinylation and glycolytic reprogramming in intestinal epithelial cells via SIRT5 modulation;Cell Biology and Toxicology;2024-08-07
4. Potential anti-liver cancer targets and mechanisms of kaempferitrin based on network pharmacology, molecular docking and experimental verification;Computers in Biology and Medicine;2024-08
5. Recent Advances on Mutant p53: Unveiling Novel Oncogenic Roles, Degradation Pathways, and Therapeutic Interventions;Biomolecules;2024-05-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3